Autoimmune Market Research Reports & Industry Analysis
Classification of autoimmune disorders is still somewhat controversial, but the following criteria is generally accepted: Direct evidence from transfer of pathogenic antibody or pathogenic T cells, indirect evidence based on reproduction of the autoimmune disease in experimental animals, and circumstantial evidence from clinical clues
Arthritis is among the most common autoimmune disorders. Arthritis is joint inflammation The major complaint by individuals who have arthritis is joint pain. Pain is often a constant and may be localized to the joint affected. There are over one hundred forms different forms The most common form, osteoarthritis (degenerative joint disease) is a result of trauma to the joint, infection of the joint, or age. Other arthritis forms are rheumatoid arthritis, psoriatic arthritis, and related autoimmune diseases. Septic arthritis is caused by joint infection. Treatment options vary depending on the type of arthritis and include physical therapy, exercise and weight control, bracing, medications. Surgery may be required in some changes.
Autoimmune Industry Research & Market Reports
-
2024 Blood & AutoImmune Diseases Global Market Size & Growth Report with Updated Analysis & Forecasts
... share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 195 countries. Figures are from 2012 through 2023, with forecasts for 2024 and 2028. The historical data ... Read More
-
Global Janus Kinase (JAK) Inhibitors Market 2024-2028
... the janus kinase (JAK) inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Systemic Lupus Erythematosus (Sle) Drugs
... is expected to reach US$362.4 Million by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. The U.S. Market is Estimated at US$63.3 Million While China is Forecast to Grow at 6.0% ... Read More
-
Immunotherapy Drugs
... at a CAGR of 9.6% over the analysis period 2023-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$254.4 Billion by the end of ... Read More
-
Thyroid Gland Disorder Treatment
... reach US$4.1 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2023-2030. Hypothyroidism, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$3.6 ... Read More
-
Cell Therapy Market Analysis and Forecast to 2033: By Cell Type (Stem, T-Cell Therapy, Dendritic, Natural Killer, Mesenchymal Stem Cell, Induced Pluripotent Stem Cell), Therapeutic Area (Oncology, Cardiovascular Disorders, Neurological Disorders, Musculoskeletal Disorders, Autoimmune Disorders, Dermatological Disorders, Others), Application (Regenerative Medicine, Tissue Engineering, Immunotherapy, Gene Therapy, Cell-Based Assays, Others), End-User (Hospitals & Clinics, Research Institutes, Biotechnology, Pharmaceutical Companies), Stage Of Development (Preclinical, Phase I, Phase II, Phase III, Commercialized), Technology (Viral Vector-Based, Non-Viral Vector-Based, Gene Editing Technologies), Mode Of Delivery (Intravenous, Intramuscular, Subcutaneous, Others), and Region
... Dermatological Disorders, Others), Application (Regenerative Medicine, Tissue Engineering, Immunotherapy, Gene Therapy, Cell-Based Assays, Others), End-User (Hospitals & Clinics, Research Institutes, Biotechnology, Pharmaceutical Companies), Stage Of Development (Preclinical, Phase I, Phase II, Phase III, Commercialized), Technology ... Read More
-
C-X-C Chemokine Receptor 4 (CXCR4) Antagonists Global Market Report 2024 Including: 1) By Type: BL-8040; GMI-1359; Plerixafor (AMD3100); Balixafortide (POL6326); USL311; Burixafor (GPC-100) 2) By Route Of Administration: Oral; Injectable 3) By Product Pipeline: Approved; Clinical Trials; Pre-Clinical 4) By Application: Cancer; Human Immunodeficiency Virus (HIV); Chronic Inflammatory Disease; Stem Cell Mobilization; Immune And Autoimmune Diseases 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies Covering: Pfizer Inc.; F-Hoffmann La Roche Ltd.; Sanofi; Bristol-Myers Squibb Company; AstraZeneca plc
... Pre-Clinical4) By Application: Cancer; Human Immunodeficiency Virus (HIV); Chronic Inflammatory Disease; Stem Cell Mobilization; Immune And Autoimmune Diseases5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online PharmaciesCovering: Pfizer Inc.; F-Hoffmann La Roche Ltd.; Sanofi; Bristol-Myers ... Read More
-
Cutaneous Lupus Erythematosus Global Market Report 2024 Including: 1) By Type: Acute; Subacute; Intermittent; Chronic 2) By Drug Class: Retinoids; Corticosteroids; Immunosuppressants; Antimalarial Drugs 3) By Route Of Administration: Oral; Injections; Topical 4) By End-Users: Hospitals; Specialty Clinics; Homecare Covering: Pfizer Inc.; Johnson & Johnson Private Limited; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.
... HomecareCovering: Pfizer Inc.; Johnson & Johnson Private Limited; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc. Cutaneous Lupus Erythematosus Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior ... Read More
-
In Vitro Diagnostics Market, Industry Trends and Global Forecasts, till 2035
... In vitro diagnostic tests (IVD) are laboratory tests that examine human samples, such as blood or tissue, outside the human body. The term ""in vitro"" comes from Latin, meaning ""within the glass,"" which refers to ... Read More
-
Lupus Therapeutics
... at a CAGR of 8.6% over the analysis period 2023-2030. Anti-Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$2.7 Billion by the end of ... Read More
-
Immunohistochemistry (IHC) Market by Product (Antibodies (Type, Clonality), Reagents, Equipment, Kits, Software), Application (Diagnostics (Cancer, Infectious, Autoimmune, Neurological), Research (Drug Development), Forensic) - Global Forecast to 2029
... USD 5.2 billion by 2029 from USD 3.7 billion in 2024, at a CAGR of 7.2% during the forecast period of 2024 to 2029. Factors propelling the growth of the market are the increased prevalence ... Read More
-
Global Nucleic Acid Therapeutics Market Size study, by Product (Anti-Sense Oligonucleotides (ASO), RNA Interference (RNAi), RNA Aptamers), by Indication (Autoimmune Disorders, Infectious Diseases, Genetic Disorders, Cancer, Others), by End-user (Hospitals, Physicians’ Offices, Others), and Regional Forecasts 2022-2032
... Forecasts 2022-2032 The Global Nucleic Acid Therapeutics Market was valued at approximately USD 6.0 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.8% over the forecast period ... Read More
-
U.S. IVD And LDT For Autoimmune Diseases Market Size, Share & Trends Analysis Report By Type (IVD, LDT), By Technology (Immunoassays, Clinical Chemistry, Hematology, Coagulation, Microbiology), By Application, By Country, And Segment Forecasts, 2024 - 203
... 2030 U.S. IVD And LDT For Autoimmune Diseases Market Growth & Trends The U.S. IVD and LDT for autoimmune diseases market size is expected to reach USD 3.70 billion by 2030, growing at a CAGR ... Read More
-
Global Immunology Market 2024-2028
... immunology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, ... Read More
-
Biologics Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Monooclonal Antibodies, Vaccines, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectius Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), Manufacturing (Outsourced and In-house), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), Manufacturing (Outsourced and In-house), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America) According to our new research study ... Read More
-
Global mRNA Vaccines and Therapeutics Market Size Study, by Vaccine Type (Self-amplifying mRNA-based Vaccines, Conventional Non-amplifying mRNA-based Vaccines), by Application (Cancer, Infectious Diseases, Autoimmune Diseases, Other Applications), by Treatment Type (Monoclonal Antibody, Gene Therapy, Cell Therapy, Other Treatment Types), by End User (Research Laboratories and Organizations, Hospitals and Clinics, Other End Users) and Regional Forecasts 2022-2032
... Therapy, Other Treatment Types), by End User (Research Laboratories and Organizations, Hospitals and Clinics, Other End Users) and Regional Forecasts 2022-2032 Global mRNA Vaccines and Therapeutics Market is valued at approximately USD 46.8 billion in ... Read More
-
Global Pemphigus Vulgaris Treatment Market - 2024-2031
... during the forecast period 2024-2031. Pemphigus vulgaris is a rare group of autoimmune diseases. It causes blisters on the skin and mucous membranes throughout the body. It can affect the mouth, nose, throat, eyes, and ... Read More
-
Veterinary Autoimmune Disease Therapeutics Global Market Report 2024
... Disease; Canine Lupus; Auto-Immune Hemolytic Anemia; Bullous Pemphigoid; Discoid Lupus Erythematosus (DLE); Immune-Related Arthritis4) By Distribution Channel: Veterinary Hospitals; Veterinary ClinicsCovering: Pfizer Inc; Merck & Co Inc; AbbVie Inc.; Sanofi S.A.; Novartis AG Veterinary Autoimmune ... Read More
-
Europe In-Vitro Diagnostics Market Forecast Report by Test Types (ELISA & CLIA, PCR, Rapid Test, Fluorescence Immunoassays (FIA), In Situ Hybridization, Transcription Mediated Amplification, Sequencing, Colorimetric Immunoassay, Radioimmunoassay (RIA), Isothermal Nucleic Acid Amplification Technology, Others) Product (Services, Instruments, Reagents) Application (Infectious Disease, Diabetes, Cardiology, Oncology, Nephrology, Autoimmune Diseases, Drug Testing, Other Applications) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics/Genetics, Hematology, Microbiology, Coagulation, Others) End User (Hospitals, Laboratories, Home - Care, Others) Countries and Company Analysis, 2024-2032
... Product (Services, Instruments, Reagents) Application (Infectious Disease, Diabetes, Cardiology, Oncology, Nephrology, Autoimmune Diseases, Drug Testing, Other Applications) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics/Genetics, Hematology, Microbiology, Coagulation, Others) End User (Hospitals, Laboratories, Home - Care, Others) ... Read More
-
Autoimmune Disease Diagnosis
... by 2030, growing at a CAGR of 5.3% over the period 2023-2030. Consumables & Assay Kits, one of the segments analyzed in the report, is expected to record 5.6% CAGR and reach US$4.1 Billion by ... Read More
-
Autoimmune Hepatitis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Italy In-Vitro Diagnostics Market Forecast Report by Test Types (ELISA & CLIA, PCR, Rapid Test, Fluorescence Immunoassays (FIA), In Situ Hybridization, Transcription Mediated Amplification, Sequencing, Colorimetric Immunoassay, Radioimmunoassay (RIA), Isothermal Nucleic Acid Amplification Technology, Others) Products (Services, Instruments, Reagents) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics/Genetics, Haematology, Microbiology, Coagulation, Others) Application (Infectious Disease, Diabetes, Cardiology, Oncology, Nephrology, Autoimmune Diseases, Drug Testing, Other Applications) End User (Hospitals, Laboratories, Home - Care, Others) and Company Analysis, 2024-2032
... Products (Services, Instruments, Reagents) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics/Genetics, Haematology, Microbiology, Coagulation, Others) Application (Infectious Disease, Diabetes, Cardiology, Oncology, Nephrology, Autoimmune Diseases, Drug Testing, Other Applications) End User (Hospitals, Laboratories, Home - Care, Others) ... Read More
-
Global Sjogrens Syndrome Therapeutics Market 2024-2028
... sjogrens syndrome therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market 2024-2028
... a CAGR of 6.78% during the forecast period. The report on the neuromyelitis optica spectrum disorder (nmosd) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor ... Read More
-
Global Autoimmune Drugs Market 2024-2028
... report on the autoimmune drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
Research Assistance
